BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific

BBC News World Edition
 You are in: Health  
News Front Page
Middle East
South Asia
Medical notes
Talking Point
Country Profiles
In Depth
BBC Sport
BBC Weather
Monday, 2 September, 2002, 23:18 GMT 00:18 UK
Heart worry for Pill jab women
Woman receives injection
The jab is administered once every three months
Women who are given long-lasting contraceptive injections may suffer physical changes which increase their risk of heart disease, claim researchers.

There is no evidence yet to directly link the jabs to heart problems.

However, the team of scientists from Imperial College School of Medicine say that there is enough evidence to concern women who already had heart risks before they started taking the drug.

They suggest that the drug may, if taken over a longer period, restrict the ability of the body's arteries to contract and expand.

This could render the arteries more vulnerable to suffer from the clogging and hardening which can lead to heart disease.

The injections are seen as a convenient alternative to taking the contraceptive pill every day or using barrier methods such as condoms.

They are often prescribed to women whom doctors think have a higher risk of heart problems because other types of contraceptive pill have already been shown to increase the risk of blood clots.

A single injection of the drug, called Depo-Provera, or DMPA, lasts for three months.

However, the latest research suggests that the jab may not prove to be an entirely risk-free alternative for some women.

Artery test

The Imperial team, led by Professor Dudley Pennell, looked at a small number of women taking DMPA.

They evaluated their arterial function by scanning the brachial artery in the arm, both at the end of a three-month DMPA cycle, and again just after the new jab.

A sample of women not taking DMPA were checked during their period, and when they were ovulating.

Widening of the arteries triggered by changes in blood flow was greatly restricted in the DMPA group - 1.1% compared with 8.0% in the non users.

This is probably happening because the injection works by blocking hormonal signals that activate ovulation.

This means that women using the drug have very low levels of oestradiol - ovarian oestrogen - in the blood.

This hormone is important in the constriction of blood vessels.

In effect, the injection is creating a temporary menopause.


Professor Pennell said that DMPA remained a highly-effective contraceptive, and was certainly safe in women who did not have any existing cardiovascular risk factors, such as smoking.

He said it was particularly effective for women who had limited access to health care, for example in developing countries - or those who had trouble complying with the routine of daily contraceptive pills.

However, he said that the kind of endothelial changes spotted by his team were the earliest warning signals that cardiovascular health was under threat.

He said that women with pre-existing risks - such as smoking, obesity, or a family history of heart trouble - should talk again to their doctor again if they were on the drug.

He told BBC News Online: "If you are on the drug simply because you have lots of cardiovascular risk factors, that may not necessarily be the best course of action.

"It would be worth reviewing that decision with your doctor."

A spokesman for the Family Planning Association said it was not prepared to comment until it had had a chance to study the research, which was published in the journal Circulation.

See also:

29 Aug 99 | Health
25 Jan 00 | Health
29 May 00 | Health
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.

E-mail this story to a friend

Links to more Health stories

© BBC ^^ Back to top

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East |
South Asia | UK | Business | Entertainment | Science/Nature |
Technology | Health | Talking Point | Country Profiles | In Depth |